• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤内微生物群:是敌是友?

The intratumoral microbiota: friend or foe?

机构信息

IRCSS Humanitas Research Hospital, Milan, Italy.

IRCSS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.

出版信息

Trends Cancer. 2023 Jun;9(6):472-479. doi: 10.1016/j.trecan.2023.03.005. Epub 2023 Apr 13.

DOI:10.1016/j.trecan.2023.03.005
PMID:37061408
Abstract

The intratumoral microbiota has been recently identified as important in cancer evasion strategies. It can induce DNA damage, favor the epithelial-mesenchymal transition, inactivate drugs, polarize the immune system toward a protumorigenic profile, induce vascular reshaping and favor metastasis formation, and protect tumor cells from fluid shear stress during cell migration. However, recently also some positive effects of the intratumoral microbiota have been highlighted such as the activation of bacterial antigen-specific responses that could be harnessed to broaden not only the immune response to tumor antigens, but also the polarization of antitumorigenic responses. As in the gut, it is likely that the ratio between symbionts and pathobionts affects the outcome. More research is needed in this field to better understand this dual role.

摘要

肿瘤内微生物群最近被确定为癌症逃避策略中的重要因素。它可以诱导 DNA 损伤,有利于上皮-间充质转化,使药物失活,使免疫系统向促肿瘤发生的表型极化,诱导血管重塑并有利于转移形成,并保护肿瘤细胞在细胞迁移过程中免受流体剪切力的影响。然而,最近也强调了肿瘤内微生物群的一些积极作用,例如激活细菌抗原特异性反应,这可以用来不仅扩大对肿瘤抗原的免疫反应,还可以使抗肿瘤反应极化。与肠道一样,共生体和病原体之间的比例可能会影响结果。需要在这一领域进行更多的研究,以更好地理解这种双重作用。

相似文献

1
The intratumoral microbiota: friend or foe?肿瘤内微生物群:是敌是友?
Trends Cancer. 2023 Jun;9(6):472-479. doi: 10.1016/j.trecan.2023.03.005. Epub 2023 Apr 13.
2
Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?肿瘤内微生物组:重塑肿瘤微环境景观的敌人还是朋友?
Cells. 2024 Jul 30;13(15):1279. doi: 10.3390/cells13151279.
3
The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment.肿瘤内微生物组对肿瘤发生、进展、预后和治疗的影响。
Front Immunol. 2022 Nov 18;13:1051987. doi: 10.3389/fimmu.2022.1051987. eCollection 2022.
4
Intratumoral microbiota: new frontiers in tumor immunity.肿瘤内微生物群:肿瘤免疫的新前沿。
Carcinogenesis. 2022 Sep 19;43(8):719-727. doi: 10.1093/carcin/bgac063.
5
Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer.肿瘤内微生物群:胰腺癌诊断与治疗的新力量。
Cancer Lett. 2023 Feb 1;554:216031. doi: 10.1016/j.canlet.2022.216031. Epub 2022 Dec 5.
6
The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer.肠道微生物群对全身和抗肿瘤免疫以及癌症全身治疗反应的影响。
Cancers (Basel). 2022 Jul 22;14(15):3563. doi: 10.3390/cancers14153563.
7
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.癌/睾丸抗原:表达、调控、肿瘤侵袭及其在癌症免疫治疗中的应用
Immunol Invest. 2016 Oct;45(7):619-40. doi: 10.1080/08820139.2016.1197241. Epub 2016 Sep 7.
8
Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.共生微生物群有助于预测非小细胞肺癌患者对免疫检查点抑制剂的反应。
Cancer Sci. 2021 Aug;112(8):3005-3017. doi: 10.1111/cas.14979. Epub 2021 Jun 23.
9
Intratumoral bacteria are an important "accomplice" in tumor development and metastasis.肿瘤内细菌是肿瘤发生发展和转移过程中的重要“帮凶”。
Biochim Biophys Acta Rev Cancer. 2023 Jan;1878(1):188846. doi: 10.1016/j.bbcan.2022.188846. Epub 2022 Dec 8.
10
The role of gut microbiota in cancer treatment: friend or foe?肠道微生物群在癌症治疗中的作用:是敌是友?
Gut. 2020 Oct;69(10):1867-1876. doi: 10.1136/gutjnl-2020-321153. Epub 2020 Aug 5.

引用本文的文献

1
Bioinformatics analysis and experimental validation of the potential relationship between bacterial lipopolysaccharide and oral squamous cell carcinoma.细菌脂多糖与口腔鳞状细胞癌潜在关系的生物信息学分析及实验验证
PLoS One. 2025 Aug 21;20(8):e0329231. doi: 10.1371/journal.pone.0329231. eCollection 2025.
2
Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy.利用肿瘤内微生物群:免疫微环境与免疫治疗的新视野
J Transl Med. 2025 Aug 12;23(1):897. doi: 10.1186/s12967-025-06916-2.
3
Gut microbiota shapes cancer immunotherapy responses.
肠道微生物群塑造癌症免疫治疗反应。
NPJ Biofilms Microbiomes. 2025 Jul 25;11(1):143. doi: 10.1038/s41522-025-00786-8.
4
Live bacteria found in gastric cancer tumor tissue.在胃癌肿瘤组织中发现活细菌。
Front Microbiol. 2025 Jun 18;16:1591735. doi: 10.3389/fmicb.2025.1591735. eCollection 2025.
5
Cancer microbiota: a focus on tumor-resident bacteria.癌症微生物群:聚焦肿瘤驻留细菌。
EMBO Rep. 2025 May 28. doi: 10.1038/s44319-025-00482-w.
6
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy.肠道微生物群对癌症免疫治疗疗效的调节作用
Gastroenterol Clin North Am. 2025 Jun;54(2):295-315. doi: 10.1016/j.gtc.2024.10.005. Epub 2025 Jan 24.
7
Designing live bacterial therapeutics for cancer.设计用于癌症治疗的活细菌疗法。
Adv Drug Deliv Rev. 2025 Jun;221:115579. doi: 10.1016/j.addr.2025.115579. Epub 2025 Apr 12.
8
The oncobiome; what, so what, now what?肿瘤微生物组;是什么、为何重要、又该如何应对?
Microbiome Res Rep. 2025 Feb 27;4(1):16. doi: 10.20517/mrr.2024.89. eCollection 2025.
9
Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma.肿瘤内真菌微生物群的异质性影响肾细胞癌的肿瘤微环境和免疫治疗结果。
Sci Adv. 2025 Apr 11;11(15):eadu1727. doi: 10.1126/sciadv.adu1727. Epub 2025 Apr 9.
10
Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota.肠道微生物群在肝细胞癌中的作用:从肠道生态失调到肿瘤内微生物群。
Cell Death Discov. 2025 Apr 4;11(1):140. doi: 10.1038/s41420-025-02413-z.